Literature DB >> 12351963

Prognostic impact of highly active antiretroviral therapy in HIV-related Hodgkin's disease.

Josep-María Ribera1, José-Tomás Navarro, Albert Oriol, Armando López-Guillermo, Anna Sureda, Eugenia Abella, Jose-Angel Hernández-Rivas, Blanca Xicoy, Javier Grau, Montserrat Batlle, Evarist Feliu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12351963     DOI： 10.1097/00002030-200209270-00020

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  7 in total

1.  Long-term follow up of patients with human immunodeficiency virus infection and advanced stage Hodgkin's lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine.

Authors:  Blanca Xicoy; Pilar Miralles; Mireia Morgades; Rafael Rubio; María-Eulalia Valencia; Josep-Maria Ribera
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

Review 2.  Hematopoietic stem cell transplantation in patients infected with HIV.

Authors:  David Serrano; Pilar Miralles; Pascual Balsalobre; José Luis Díez-Martin; Juan Berenguer
Journal:  Curr HIV/AIDS Rep       Date:  2010-08       Impact factor: 5.071

Review 3.  Hodgkin lymphoma in patients with HIV infection: a review.

Authors:  Nihal Martis; Nicolas Mounier
Journal:  Curr Hematol Malig Rep       Date:  2012-09       Impact factor: 3.952

Review 4.  How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus.

Authors:  Thomas S Uldrick; Richard F Little
Journal:  Blood       Date:  2014-12-11       Impact factor: 22.113

Review 5.  Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era.

Authors:  Roger Bedimo
Journal:  Curr HIV/AIDS Rep       Date:  2008-08       Impact factor: 5.071

6.  Advanced stage is the most important prognostic factor for survival in patients with systemic acquired immunodeficiency syndrome-related non-Hodgkin's Lymphoma treated with CHOP and highly active antiretroviral therapy.

Authors:  José-Tomás Navarro; Josep-Maria Ribera; Albert Oriol; Blanca Xicoy; José-Luis Mate; Guillem Sirera; Natalia Lloveras; Fuensanta Millá; Evarist Feliu
Journal:  Int J Hematol       Date:  2007-11       Impact factor: 2.490

7.  Outcome of patients with HIV-related germ cell tumours: a case-control study.

Authors:  T Powles; M Bower; J Shamash; J Stebbing; J Ong; G Daugaard; A De Ruiter; M Johnson; M Fisher; J Anderson; M Nelson; B Gazzard; T Oliver
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.